Phospho-REL (S503) Antibody

What is Phospho-REL (S503) Antibody and what does it specifically detect?

Phospho-REL (S503) Antibody is a rabbit polyclonal antibody specifically designed to detect the c-Rel protein only when phosphorylated at serine 503. The antibody recognizes the phosphorylated form of c-Rel at this specific site, making it valuable for investigating post-translational modifications of this protein in signaling pathways . The specificity of this antibody is crucial for distinguishing between phosphorylated and non-phosphorylated forms of c-Rel, which can have different functional activities within cellular contexts. The antibody is typically generated using synthetic phosphopeptides corresponding to amino acids surrounding the S503 phosphorylation site of human c-Rel .

What is the biological significance of c-Rel phosphorylation at S503?

The phosphorylation of c-Rel at S503 represents an important post-translational modification with significant implications for NF-κB signaling pathways. c-Rel is a proto-oncogene that plays crucial roles in cellular differentiation and lymphopoiesis . As a member of the NF-κB family, phosphorylated c-Rel participates in numerous biological processes including inflammation, immunity, cellular differentiation, growth regulation, tumorigenesis, and apoptosis . Phosphorylation at S503 can alter c-Rel's DNA binding affinity, transcriptional activity, protein-protein interactions, and subcellular localization. This modification is particularly significant in immune cell function and may represent a regulatory checkpoint in NF-κB-mediated transcriptional programs involved in immune responses and cancer development .

How does c-Rel (S503) phosphorylation relate to the broader NF-κB signaling network?

c-Rel phosphorylation at S503 should be understood within the broader context of NF-κB signaling. NF-κB functions as a homo- or heterodimeric complex formed by Rel-like domain-containing proteins including RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL, and NFKB2/p52 . These dimers bind to κB sites in target gene DNA with distinct preferences and specificities. Different dimer combinations can function as either transcriptional activators or repressors . The NF-κB heterodimer composed of RELA/p65 and c-Rel specifically acts as a transcriptional activator . Phosphorylation events, including c-Rel S503 phosphorylation, represent one of several post-translational modifications that regulate NF-κB activity, alongside acetylation and subcellular compartmentalization . Similar to how phosphorylation of RelA at serines 276 and 536 regulates its acetylation at lysine 310 , c-Rel S503 phosphorylation likely participates in a coordinated series of modifications that fine-tune its transcriptional activity.

Experimental Applications and Methodologies

For successful immunoprecipitation (IP) using Phospho-REL (S503) Antibody, researchers should follow this methodological approach:

• Prepare cell lysates in an appropriate lysis buffer (e.g., 50 mM HEPES, pH 7.4, 250 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM PMSF) containing protease and phosphatase inhibitor cocktails to preserve phosphorylation status .

• Clear lysates by centrifugation (14,000 × g for 15 minutes at 4°C) and quantify protein concentration.

• Pre-clear lysates with Protein A agarose beads for 1 hour at 4°C to reduce non-specific binding.

• Incubate pre-cleared lysates with Phospho-REL (S503) Antibody (typically 2-5 μg per 1 mg of total protein) overnight at 4°C with gentle rotation.

• Add Protein A agarose beads and incubate for 2-4 hours at 4°C.

• Wash immunoprecipitates 4-5 times with cold lysis buffer.

• Elute bound proteins by boiling in SDS-PAGE sample buffer and analyze by Western blotting.

This protocol can be modified depending on experimental needs and should be optimized for specific cell types and conditions. When investigating stimulus-induced phosphorylation, include appropriate time-course experiments to capture the dynamics of c-Rel S503 phosphorylation .

How can Phospho-REL (S503) Antibody be used in chromatin immunoprecipitation (ChIP) assays?

Chromatin immunoprecipitation using Phospho-REL (S503) Antibody allows researchers to investigate DNA binding of phosphorylated c-Rel and identify target genes regulated by this modification. A methodological approach based on established ChIP protocols for NF-κB family members includes:

• Cross-link protein-DNA complexes in cells using 1% formaldehyde for 10 minutes at room temperature .

• Lyse cells and sonicate chromatin to generate DNA fragments of approximately 200-1000 bp .

• Pre-clear chromatin with Protein A agarose beads.

• Immunoprecipitate with Phospho-REL (S503) Antibody overnight at 4°C (use IgG as a negative control and total c-Rel antibody as a positive control) .

• Add Protein A agarose beads and incubate for 2-4 hours at 4°C.

• Wash the immunoprecipitates extensively with low-salt, high-salt, LiCl, and TE buffers.

• Elute the protein-DNA complexes and reverse cross-links by heating.

• Purify DNA and analyze by qPCR targeting promoter regions of interest or perform sequencing.

This approach allows researchers to identify genes specifically regulated by phosphorylated c-Rel at S503, providing insights into the transcriptional consequences of this modification in different cellular contexts .

How does phosphorylation at S503 impact c-Rel function compared to other phosphorylation sites?

c-Rel contains multiple phosphorylation sites that can be differentially regulated depending on cellular context and stimuli. The functional impact of S503 phosphorylation should be considered in relation to other modifications. While S503 phosphorylation is important, its effects may depend on the phosphorylation status of other sites. Similar to how RelA phosphorylation at serines 276 and 536 regulates its acetylation at lysine 310 , c-Rel S503 phosphorylation likely participates in a coordinated network of modifications.

Researchers studying S503 phosphorylation should consider these methodological approaches:

• Use phospho-specific antibodies against multiple sites to assess their relative phosphorylation patterns under various conditions.

• Employ site-directed mutagenesis to create phospho-mimetic (S503D/E) and phospho-deficient (S503A) mutants to dissect functional consequences.

• Apply comparative protein mass spectrometry to identify all phosphorylation sites and their relative stoichiometry.

• Perform time-course analyses to determine the sequence and dynamics of multiple phosphorylation events.

This comprehensive approach can reveal how S503 phosphorylation coordinates with other modifications to regulate c-Rel's diverse functions in different cellular contexts .

What are the kinases responsible for c-Rel S503 phosphorylation and how can they be experimentally verified?

Identifying the specific kinases responsible for c-Rel S503 phosphorylation represents an important research question. While the search results don't specifically identify these kinases, researchers can employ several experimental approaches to identify and validate them:

• In silico analysis: Examine the amino acid sequence surrounding S503 for consensus kinase recognition motifs.

• Kinase inhibitor screening: Treat cells with a panel of specific kinase inhibitors and assess S503 phosphorylation status using the Phospho-REL (S503) Antibody.

• Kinase overexpression and knockdown: Overexpress candidate kinases or reduce their expression using siRNA/shRNA and evaluate effects on S503 phosphorylation.

• In vitro kinase assays: Perform reactions using purified kinases and c-Rel protein or peptides containing the S503 site.

• Proximity ligation assays: Detect direct interaction between candidate kinases and c-Rel in intact cells.

These approaches can be used in combination to identify and validate kinases responsible for S503 phosphorylation, which may include members of the IKK family or other kinases involved in NF-κB signaling pathways .

How does the phosphorylation status of c-Rel at S503 change in different disease models?

The phosphorylation status of c-Rel at S503 may be altered in various disease conditions, particularly those involving dysregulated inflammation, immune responses, or cancer. To investigate these changes, researchers can employ these methodological approaches:

• Comparative tissue analysis: Use Phospho-REL (S503) Antibody in immunohistochemistry to compare phosphorylation levels between normal and diseased tissues from patients or animal models .

• Cell culture disease models: Establish relevant disease models in cell culture and assess S503 phosphorylation in response to disease-relevant stimuli.

• Animal models: Generate or utilize existing disease models (e.g., inflammation, autoimmunity, cancer) and analyze tissues for changes in c-Rel S503 phosphorylation.

• Single-cell analysis: Apply phospho-flow cytometry to analyze S503 phosphorylation at the single-cell level in heterogeneous populations.

• Correlation studies: Correlate S503 phosphorylation levels with disease progression, severity, or treatment response.

These approaches can yield insights into how c-Rel S503 phosphorylation contributes to disease pathogenesis and potentially identify novel therapeutic targets within the NF-κB pathway .

How can researchers ensure specificity when using Phospho-REL (S503) Antibody?

Ensuring antibody specificity is critical for obtaining reliable results. Researchers should implement the following methodological approaches to confirm specificity of the Phospho-REL (S503) Antibody:

• Peptide competition assay: Pre-incubate the antibody with the phosphorylated peptide used as immunogen to block specific binding, and with the non-phosphorylated peptide as a control.

• Phosphatase treatment: Treat samples with lambda phosphatase to remove phosphorylation and confirm loss of signal.

• Genetic controls: Use cells with c-Rel knockdown/knockout or expressing S503A mutant to validate specificity.

• Stimulation controls: Compare unstimulated cells with those treated with stimuli known to induce NF-κB activation.

• Cross-reactivity testing: Test reactivity against related NF-κB family members, particularly those with similar phosphorylation sites.

• Antibody validation: Select antibodies that have undergone rigorous purification, such as affinity purification using phospho-specific peptides with non-phospho specific antibodies removed through chromatography .

These validation steps are essential for confirming that observed signals genuinely represent c-Rel phosphorylated at S503, particularly in complex experimental settings.

What are the critical factors for preserving phosphorylation status during sample preparation?

Phosphorylation is a labile modification that can be rapidly lost during sample preparation due to endogenous phosphatase activity. To preserve the phosphorylation status of c-Rel at S503, researchers should:

• Use appropriate lysis buffers: Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) in all buffers.

• Maintain cold temperature: Perform all steps at 4°C to minimize enzymatic activity.

• Add protease inhibitors: Prevent degradation of the target protein with a complete protease inhibitor cocktail.

• Optimize lysis conditions: Use buffers containing appropriate detergents (e.g., NP-40, Triton X-100) to effectively solubilize c-Rel while preserving phosphorylation.

• Rapid processing: Minimize the time between sample collection and analysis.

• Avoid repeated freeze-thaw cycles: Prepare aliquots of samples for single use to prevent degradation.

• Consider denaturing conditions: For some applications, immediate denaturation of proteins (e.g., with hot SDS buffer) can effectively inactivate phosphatases.

Implementing these practices will help ensure that the phosphorylation status of c-Rel at S503 accurately reflects its state within the cell prior to lysis .

How can researchers quantify changes in c-Rel S503 phosphorylation levels accurately?

Accurate quantification of phosphorylation changes is essential for understanding signaling dynamics. Researchers should consider these methodological approaches:

• Normalization strategies: Always normalize phospho-specific signals to total c-Rel protein levels to account for variations in total protein expression.

• Standard curves: Include standard samples with known quantities of phosphorylated and total c-Rel for accurate quantification.

• Multiple technical replicates: Perform at least three technical replicates for each biological sample.

• Appropriate controls: Include positive controls (stimulated samples) and negative controls (phosphatase-treated or S503A mutant samples).

• Digital image analysis: Use software with linear dynamic range for quantification of Western blot or immunofluorescence signals.

• Alternative quantitative methods: Consider using ELISA, AlphaLISA, or mass spectrometry-based approaches for more precise quantification.

• Statistical analysis: Apply appropriate statistical tests based on experimental design and data distribution.

• Time-course experiments: Perform detailed time-course analyses to capture the dynamics of phosphorylation changes.

What are the most common issues when using Phospho-REL (S503) Antibody in Western blotting and how can they be resolved?

Researchers frequently encounter challenges when using phospho-specific antibodies in Western blotting. The following table outlines common issues with Phospho-REL (S503) Antibody and their solutions:

Implementing these troubleshooting approaches can significantly improve the quality and reliability of Western blot data when working with Phospho-REL (S503) Antibody .

How can researchers overcome challenges in detecting phosphorylated c-Rel in tissue samples?

Detecting phosphorylated proteins in tissue samples presents unique challenges due to tissue heterogeneity, fixation effects, and variable phosphorylation levels. To overcome these challenges when using Phospho-REL (S503) Antibody in tissue sections, researchers should:

• Optimize fixation: Use freshly prepared fixatives and optimize fixation time to preserve phospho-epitopes while maintaining tissue morphology.

• Antigen retrieval: Test different antigen retrieval methods (heat-induced, enzymatic) to maximize accessibility of the phospho-epitope.

• Signal amplification: Consider using signal amplification systems (tyramide signal amplification, polymer-based detection) to enhance sensitivity.

• Controls: Include phosphatase-treated sections as negative controls and stimulated cell pellets as positive controls.

• Counterstaining: Use appropriate nuclear counterstains to facilitate identification of nuclear phospho-c-Rel.

• Multiplex staining: Combine phospho-c-Rel staining with markers for specific cell types to identify cell populations with active signaling.

• Digital pathology: Use image analysis software for objective quantification of staining intensity and distribution.

• Fresh frozen tissues: Consider using fresh frozen tissues when possible, as they often better preserve phospho-epitopes compared to formalin-fixed samples.

These approaches can significantly improve the detection and analysis of phosphorylated c-Rel at S503 in complex tissue environments .

What strategies can be employed when phosphorylation-specific signal is difficult to detect?

When phosphorylated c-Rel at S503 is difficult to detect, researchers can employ several advanced strategies to enhance detection:

• Phosphorylation enrichment: Use phospho-protein or phospho-peptide enrichment techniques (e.g., metal oxide affinity chromatography, phospho-specific antibody-based enrichment) prior to analysis.

• Cell fractionation: Isolate nuclear fractions where activated c-Rel is expected to accumulate following phosphorylation.

• Stimulus optimization: Test different stimuli, concentrations, and time points to identify conditions that maximize S503 phosphorylation.

• Inhibit opposing pathways: Use phosphatase inhibitors (e.g., okadaic acid, calyculin A) to block dephosphorylation pathways.

• Kinase co-expression: Co-express c-Rel with kinases suspected to phosphorylate S503 to increase phosphorylation levels.

• Alternative detection methods: Consider more sensitive techniques such as Phos-tag SDS-PAGE, which can separate phosphorylated from non-phosphorylated proteins.

• Super-resolution microscopy: Use advanced imaging techniques to visualize subcellular localization of phosphorylated c-Rel with greater precision.

• Proximity ligation assay: Detect phosphorylated c-Rel in situ with high sensitivity using antibodies against c-Rel and phospho-serine.

These approaches can help overcome detection challenges and reveal subtle changes in c-Rel S503 phosphorylation that might be missed with standard techniques .

How can phospho-proteomics be used alongside Phospho-REL (S503) Antibody to study NF-κB signaling networks?

Integrating antibody-based detection with phospho-proteomics offers a powerful approach to studying NF-κB signaling networks. Researchers can implement the following methodological strategy:

• Global phosphorylation profiling: Perform unbiased phospho-proteomics to identify all phosphorylation changes occurring in response to stimuli that activate NF-κB signaling.

• Pathway mapping: Map identified phosphorylation sites onto known signaling pathways to contextualize c-Rel S503 phosphorylation within the broader network.

• Temporal dynamics: Compare the kinetics of c-Rel S503 phosphorylation (detected by antibody) with other phosphorylation events to establish signaling hierarchies.

• Phospho-site stoichiometry: Use mass spectrometry-based approaches to determine the fraction of c-Rel phosphorylated at S503 under different conditions.

• Multi-site phosphorylation analysis: Identify other phosphorylation sites on c-Rel and determine their interdependencies with S503 phosphorylation.

• Interactome changes: Combine phospho-proteomics with interaction proteomics to identify proteins that differentially associate with c-Rel based on its S503 phosphorylation status.

• Validation: Use Phospho-REL (S503) Antibody to validate and further investigate specific findings from the phospho-proteomic analysis.

This integrated approach provides a comprehensive view of how c-Rel S503 phosphorylation is positioned within the complex signaling networks that regulate NF-κB-dependent gene expression .

What are the considerations for using Phospho-REL (S503) Antibody in high-throughput screening approaches?

Adapting Phospho-REL (S503) Antibody for high-throughput screening (HTS) applications requires careful methodological considerations:

• Assay format selection: Choose an appropriate format (e.g., ELISA, AlphaLISA, high-content imaging) that balances throughput, sensitivity, and specificity.

• Miniaturization: Optimize antibody concentrations and reaction volumes for microplate formats (384- or 1536-well).

• Positive and negative controls: Include appropriate controls on each plate to enable quality control and normalization.

• Assay validation: Determine Z-factor, signal-to-background ratio, and coefficient of variation to ensure assay robustness.

• Automation compatibility: Ensure all steps are compatible with liquid handling systems and automated workflows.

• Data normalization: Develop and validate methods to normalize data across plates and experimental batches.

• Counter-screening: Implement secondary assays to confirm hits and eliminate false positives.

• Data analysis pipeline: Establish computational pipelines for data processing, hit identification, and pathway analysis.

These considerations will enable researchers to effectively use Phospho-REL (S503) Antibody in HTS campaigns aimed at identifying modulators of c-Rel phosphorylation or downstream signaling events .

How can computational modeling integrate experimental data from Phospho-REL (S503) Antibody studies?

Computational modeling can enhance the interpretation of experimental data generated using Phospho-REL (S503) Antibody. Researchers can implement the following approaches:

• Kinetic modeling: Develop mathematical models of the NF-κB pathway that incorporate c-Rel S503 phosphorylation kinetics measured using the antibody.

• Network inference: Use phosphorylation data to infer regulatory relationships between c-Rel and other signaling components.

• Structural modeling: Predict how S503 phosphorylation affects c-Rel protein conformation and interaction surfaces using molecular dynamics simulations.

• Machine learning: Apply supervised learning approaches to identify patterns in phosphorylation data that predict functional outcomes.

• Multi-scale modeling: Integrate molecular, cellular, and tissue-level data to understand how c-Rel S503 phosphorylation influences higher-order biological processes.

• Sensitivity analysis: Identify the most critical parameters in the NF-κB signaling network that affect c-Rel S503 phosphorylation.

• In silico perturbation: Simulate the effects of drugs, mutations, or knockdowns on c-Rel S503 phosphorylation and validate experimentally.

• Comparative modeling: Model differences in c-Rel phosphorylation dynamics across cell types or disease states based on experimental data.

These computational approaches can generate testable hypotheses about the regulation and function of c-Rel S503 phosphorylation within complex biological systems .

What are the emerging research areas involving c-Rel S503 phosphorylation?

Several emerging research areas offer promising opportunities for investigating c-Rel S503 phosphorylation:

• Single-cell analysis: Applying single-cell phospho-proteomics and imaging to understand cell-to-cell variability in c-Rel S503 phosphorylation and its functional consequences.

• Spatial signaling: Investigating how subcellular localization affects the regulation and function of S503-phosphorylated c-Rel using advanced imaging techniques.

• Cross-talk with other pathways: Exploring how c-Rel S503 phosphorylation integrates signals from multiple pathways beyond canonical NF-κB activation.

• Epigenetic regulation: Examining how S503-phosphorylated c-Rel influences chromatin structure and epigenetic modifications to regulate gene expression.

• Therapeutic targeting: Developing strategies to specifically modulate c-Rel S503 phosphorylation for therapeutic purposes in inflammation and cancer.

• Tissue-specific functions: Characterizing tissue-specific roles of c-Rel S503 phosphorylation in physiology and pathology.

• Evolutionary conservation: Comparing c-Rel phosphorylation mechanisms across species to understand evolutionary conservation and divergence.

• Microenvironmental influences: Investigating how the cellular microenvironment modulates c-Rel S503 phosphorylation in complex tissues.

These research directions will expand our understanding of c-Rel S503 phosphorylation and its significance in health and disease .

What are the most effective experimental systems for studying c-Rel S503 phosphorylation?

Selecting appropriate experimental systems is crucial for advancing research on c-Rel S503 phosphorylation. Researchers should consider these methodological options:

• Cell lines: Immune cell lines (e.g., Jurkat, THP-1) and cancer cell lines with active NF-κB signaling provide accessible systems for mechanistic studies.

• Primary cells: Primary immune cells (T cells, B cells, macrophages) offer physiologically relevant contexts for studying c-Rel function.

• Inducible systems: Tet-regulated expression systems for wild-type and mutant c-Rel allow controlled studies of phosphorylation dynamics.

• CRISPR-engineered cells: Cells with endogenous c-Rel edited to contain S503A or S503D mutations provide powerful tools for functional studies.

• Ex vivo tissue cultures: Primary tissue explants maintain the complexity of in vivo environments while allowing experimental manipulation.

• Animal models: Knock-in mice expressing phospho-mutant c-Rel can reveal physiological roles of S503 phosphorylation.

• Patient-derived samples: Analysis of clinical samples can establish relevance to human disease.

• Organoids and 3D cultures: These systems better recapitulate tissue architecture and cell-cell interactions than traditional 2D cultures.

Each system offers distinct advantages, and researchers should select based on their specific research questions and available resources .

How might understanding c-Rel S503 phosphorylation contribute to therapeutic development?

Understanding c-Rel S503 phosphorylation has significant potential to inform therapeutic development for various diseases involving dysregulated NF-κB signaling:

• Target identification: Characterizing kinases and phosphatases that regulate S503 phosphorylation may reveal druggable targets.

• Biomarker development: c-Rel S503 phosphorylation status could serve as a biomarker for NF-κB pathway activation in patient samples.

• Rational drug design: Structural insights into how S503 phosphorylation alters c-Rel function can guide the design of small molecules that mimic or disrupt these effects.

• Combination therapies: Understanding how c-Rel S503 phosphorylation interacts with other signaling pathways can inform effective drug combinations.

• Cell type-specific interventions: Identifying cell type-specific regulation of c-Rel S503 phosphorylation may enable more targeted therapeutic approaches.

• Patient stratification: Patterns of c-Rel phosphorylation could help stratify patients for clinical trials or personalized treatment approaches.

• Immunomodulatory strategies: Modulating c-Rel S503 phosphorylation could offer new approaches to immune system regulation in autoimmunity, inflammation, and cancer.

• Gene therapy approaches: Gene editing technologies could be used to modify c-Rel phosphorylation sites in specific therapeutic contexts.